- Home
- VRCA vs PPT Comparison
VRCA vs PPT Comparison
Compare VRCA & PPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- PPT
- Stock Information
- Founded
- VRCA 2013
- PPT 1988
- Country
- VRCA United States
- PPT United States
- Employees
- VRCA N/A
- PPT N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- PPT Finance Companies
- Sector
- VRCA Health Care
- PPT Finance
- Exchange
- VRCA Nasdaq
- PPT Nasdaq
- Market Cap
- VRCA 363.1M
- PPT 353.3M
- IPO Year
- VRCA 2018
- PPT N/A
- Fundamental
- Price
- VRCA $0.75
- PPT $3.61
- Analyst Decision
- VRCA Buy
- PPT
- Analyst Count
- VRCA 6
- PPT 0
- Target Price
- VRCA $7.33
- PPT N/A
- AVG Volume (30 Days)
- VRCA 646.5K
- PPT 156.1K
- Earning Date
- VRCA 11-04-2024
- PPT 01-01-0001
- Dividend Yield
- VRCA N/A
- PPT 8.84%
- EPS Growth
- VRCA N/A
- PPT N/A
- EPS
- VRCA N/A
- PPT N/A
- Revenue
- VRCA $9,210,000.00
- PPT N/A
- Revenue This Year
- VRCA $291.12
- PPT N/A
- Revenue Next Year
- VRCA $104.31
- PPT N/A
- P/E Ratio
- VRCA N/A
- PPT N/A
- Revenue Growth
- VRCA 187.45
- PPT N/A
- 52 Week Low
- VRCA $0.70
- PPT $3.25
- 52 Week High
- VRCA $11.41
- PPT $3.72
- Technical
- Relative Strength Index (RSI)
- VRCA 26.09
- PPT 44.03
- Support Level
- VRCA $1.40
- PPT $3.55
- Resistance Level
- VRCA $1.74
- PPT $3.62
- Average True Range (ATR)
- VRCA 0.13
- PPT 0.03
- MACD
- VRCA -0.06
- PPT -0.00
- Stochastic Oscillator
- VRCA 0.00
- PPT 41.58
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About PPT Putnam Premier Income Trust
Putnam Premier Income Trust is a Massachusetts business trust operating as a non-diversified closed-end management investment company. The fund is currently operating as a diversified fund. Its investment objective is to seek high current income consistent with the preservation of capital by allocating its investments to the U.S. government sector.